Matinas BioPharma Holdings, Inc. (MTNB) is “One to Watch”
Matinas BioPharma Holdings, Inc. (OTCQB: MTNB), is a biopharmaceutical company still in its clinical stages, focused on identifying and developing treatments for fungal and bacterial infections. Founded in 2012, the company’s goal is to change the way in which potent medicines are delivered and administered, with the aim of giving both physicians and patients better, safer, and more effective solutions to fight these infections. MTNB is working toward unique benefits through its lead drug candidates, MAT2501 and MAT2203. These benefits include oral administration and bioavailability, multi-organ protection, and targeted delivery directly to the infected areas. MAT2501 is used to treat…







